logo
16:01 Jan 20

Parnax Lab Ltd.

Sector Pharmaceuticals & Biotechnology Industry Pharmaceuticals
Up
111.50
-2.50 (-2.19%)
Sector Pharmaceuticals & Biotechnology Industry Pharmaceuticals

Parnax Lab Ltd. Financials

Parnax Lab Ltd.
Sector Pharmaceuticals & Biotechnology
Industry Pharmaceuticals
Up
111.50
-2.50 (-2.19%)
16:01 Jan 20
Quality
image/svg+xml

63/100
High Financial Strength

Valuation
image/svg+xml

56/100
Affordable Valuation

Technical

43/100
Technically Neutral

Strength

7

Weakness

3

Opportunity

0

Threats

0

13.86 %

ROE %

6.06 %

ROA %

9.59

EPS

72.35

BVPS

6.13 %

Net Profit Margin

Mar 2022 Mar 2023 Mar 2024 Mar 2025 TTM 2025
Net Sales
163.03 167.61 188.71 187.74 205.24
Operating Expenses +
140 144.62 165.17 160.97 178.82
Raw Material
91.3 89.35 104.89 94.31 116.9
Increase Decrease in Cost
-1.66 -0.53 -2.07 1.69 -2.75
Other Manufacturing Expense
25.37 27.52 30.47 29.01 0
Employee Cost
17.43 20.05 23.72 24.43 24.72
Miscellaneous Expenses
7.9 9.63 8.46 12.45 39.95
Operating Profit
23.03 22.99 23.54 26.77 26.42
Other Income
0.33 0.77 0.82 1.68 1.43
Depreciation
5.87 6.53 6.96 7.38 7.65
Interest
5.23 4.95 5.35 5.39 5.13
Profit before tax and exceptio..
12.26 12.28 12.05 15.67 15.07
Exceptional Items
0 0 0 0 0
PBT
12.26 12.28 12.05 15.67 15.07
Provision for Taxation
4.01 3.65 2.42 4.14 4.03
Net Profit
8.26 8.63 9.62 11.54 11.03
NET Profit after MI
8.24 8.62 9.61 11.52 11.02
EPS
9.7 7.8 8.38 10.05 9.61
Operating Profit Margin (%)
14.13 13.72 12.47 14.26 12.87
Net Profit Margin (%)
5.05 5.14 5.09 6.14 5.37

Parnax Lab Ltd. Shareholding

Promoter

FII

Public

All Data in Percentage (%)

Jun 2024 Sep 2024 Dec 2024 Mar 2025 Jun 2025 Sep 2025
Promoter 72.30 72.30 72.30 72.30 72.30 72.30
FII 0.00 0.00 0.00 0.00 0.00 0.00
Public 0.00 0.00 0.00 0.00 0.00 0.00
Others 27.70 27.70 27.70 27.70 27.70 27.70
Shareholder Shares Holding %
Research 360 logo
Download Our App On: